TNFRSF18 and cancer: GITR’s central role in immune system regulation has garnered attention for immunotherapeutic cancer treatment and led to the development of anti-GITR antibodies that are proposed to mimic the ability of the endogenous GITRL to cluster receptors into high-order arrays.